Table 2.
Immune correlate | Significance | NHP model |
---|---|---|
sCD14 | Marker of microbial translocation in SIV, prediction of immune activation in TB/HIV coinfection | Rhesus macaque—SIV model |
CRP | Soluble markers of inflammation, monocyte turnover, fibrosis predict progression to AIDS and death | Rhesus macaque—TB and SHIV/SIV model |
IL-6 | ||
IL-8 | ||
IP-10 | Independent marker of rapid disease onset in HIV | Rhesus/Cynomolgus macaque—SIV, TB model |
HLA-DR | T-cell activation marker, predisposes to SIV and TB progression, shorter survival, mortality upon cART initiation | |
CD38 | ||
IL-2Rα | Marker of T-helper function |
Sooty mangabeys—SIV model Rhesus macaque—TB model |
CD45RO | Marker for primed/memory T cells | Rhesus macaque—SIV model |
ESAT-6/CFP-10 specific CD4+ T cells | Key immune cell type required to contain Mtb within granulomas | Rhesus, Mauritian cynomolgus macaques—TB/SIV model |
IFNg+IL-2+TNFa+ T cells | Marker of disease control and protection against depletion of mucosal CD4+ T cells | Rhesus macaque—TB and SIV model |
CD4+CD25+CD127- Tregs | Marker to differentiate intestinal Tregs from lymphoid tissue Tregs in TB and SIV infections |
Cynomolgus macaque—TB model Rhesus macaque—SIV model |
Monocyte:Lymphocyte ratio | Marker to distinguish between ATB, LTBI; prediction of TB risk in infants | Rhesus, Chinese and Mauritian Cynomolgus macaque—TB model |
Granzyme B | Cytotoxic T -lymphocyte mediated defence against intracellular pathogens |
Rhesus, Cynomolgus macaque—TB model Rhesus macaque—SIV model |
CD8+memory T cells | Suppression of viremia by rapid expansion and localization within B-cell follicles in SIV; immunity against Mtb reinfection | Rhesus macaque—TB and SIV model |
Th17 response | Significantly reduced in SIV, can reduce Mtb control in lungs | Rhesus macaque—SIV model |